Ponatinib Impurity 37 CAS 2098039-04-2

Purity ≥95%In StockPharmacopoeial Impurity Standards
CAS No.2098039-04-2
Molecular FormulaC8H5N3
Molecular Weight143.15 g/mol
CategoryPharmacopoeial Impurity Standards / EP Impurities
AvailabilityIn Stock

Chemical Structure

Ponatinib Impurity 37 CAS 2098039-04-2 chemical structure

Description

The occurrence of Ponatinib Impurity 37 is closely related to a nitrogen-containing heterocyclic scaffold, a nitrile group in its molecular formula, which determines its behaviour during synthesis, purification, or degradation.

CATO supplies Ponatinib Impurity 37 (CAS 2098039-04-2), a pharmacopoeial impurity reference standard (molecular formula C8H5N3, MW 143.15 g/mol) used for the identification and quantification of trace impurities in APIs.

Ponatinib Impurity 37 (C8H5N3) contains a nitrogen-containing heterocyclic scaffold, a nitrile group. Its physicochemical properties are representative of its class; these physicochemical properties determine the optimal preparation and storage of its standard solutions. The aromatic system may exhibit native fluorescence, enabling detection with a fluorescence detector (FLD).

Recommended for quantitative analysis by HPLC, GC, LC-MS/MS, or GC-MS as an external calibration standard; it can also be used for spiked-recovery experiments, LOD/LOQ determination, and LC-MS/MS multiple-reaction-monitoring (MRM) calibration.

The assigned purity is verified by mass-balance and quantitative NMR (qNMR) approaches, with the expanded uncertainty reported at a 95% confidence level (k=2). Batch homogeneity and stability are independently assessed for every lot.

Physical & Chemical Properties

Molecular FormulaC8H5N3
Molecular Weight143.15 g/mol
Purity≥95%
StorageStore at 2-8°C, protect from light
Solubility (reference)Soluble in DMSO, DMF, methanol
StabilityLight-sensitive; avoid direct strong light
Degree of Unsaturation (DBE)8.0
UV AbsorptionUV-absorbing
Structural FeaturesAromatic ring present
CAS Registry Year (est.)1997
Nitrogen Atoms3

Related Ponatinib Standards

Recommended Standards

Why CATO?